Risk of PROM and preterm PROM increased with vitamin C and E supplements.
Risk of premature rupture of the membranes (PROM) and preterm PROM (PPROM) unexpectedly increased with vitamin C and E supplementation, according to a report in the October issue of the American Journal of Obstetrics and Gynecology.
Joseph A. Spinnato II, MD, of the University of Cincinnati College of Medicine, and colleagues report on a planned secondary analysis of a placebo-controlled, double-blind trial examining antioxidant supplementation during pregnancy. The report focuses on the incidence of PROM and PPROM in women receiving either 1,000 mg of vitamin C and 400 IU of vitamin E daily, or placebo.
Overall, PROM (10.6%) and PPROM (4.6%) were more common with antioxidant supplementation than with placebo (5.5% and 1.7%, respectively), the researchers report. Adjusted risk ratios indicated pregnant patients receiving antioxidant supplementation were 1.89 times more likely to develop PROM and 2.68 times more likely to develop PPROM than those taking placebo, the report indicates.
Spinnato JA 2nd, Freire S, Pinto e Silva JL, et al. Antioxidant supplementation and premature rupture of the membranes: a planned secondary analysis. Am J Obstet Gynecol. 2008;199:433.e1-.e8.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More